Article Details
Retrieved on: 2022-03-21 06:49:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
His team at UQ's Australian Institute for Bioengineering and Nanotechnology (AIBN) will study disease progression, screen medicines and ultimately ...
Article found on: aibn.uq.edu.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here